Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE...
Day: February 21, 2025
ZEISS Shapes the Future of Metrology with Cutting-Edge Technologies Revealed at Event
ZEISS Industrial Quality Solutions will host its first-ever digital launch event for the USA and Canada, introducing seven metrology innovations...
The OhmX RAMP UP Grant Awarded to 15 Laboratories to Advance Genomic Research
PROVIDENCE, R.I., Feb. 21, 2025 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys) and Hitachi High-Tech America, Inc. (HTA) have revealed the...
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
Longstanding partners bring together end-to-end workflows and leading CRISPRPerturb-seq technologies setting a standard for single-cell studies and enabling a 5billion...
Guidehouse Appoints New Healthcare Technology and Managed Services Leaders
Erik Barnett and Brian Smit to power firm's commitment to AI-driven transformation and revenue cycle efficiency MCLEAN, Va., Feb. 21,...
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
MENLO PARK, Calif., Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
National Press Club Journalism Institute announces training series to support public health journalism
WASHINGTON, Feb. 21, 2025 /PRNewswire/ -- Solutions-oriented journalism about America's public health landscape has become increasingly important as disinformation continues to...
Walker Healthforce Successfully Achieves ISO/IEC 27001 Certification
BLOOMFIELD HILLS, Mich., Feb. 21, 2025 /PRNewswire/ -- Walker Healthforce (www.walkerhealthforce.com), a Certified Woman and Minority owned (WMBE) healthcare technology...
Coreline Soft Leads AI Medical Imaging Innovation at STR 2025
Introducing the AVIEW lineup specialized in simultaneous diagnosis and analysis of thoracic diseasesParticipating in HIMSS on March 3rd and completing...
Safe Supply Streaming Co Ltd. Announces Completion of Safety Strips Tech Corp. Acquisition
Toronto, Ontario--(Newsfile Corp. - February 21, 2025) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
Ensho Therapeutics Announces Presentation of Data Highlighting NSHO-101 as a Once-Daily Oral Agent for the Potential Treatment of Inflammatory Bowel Disease at ECCO 2025
MORRIS PLAINS, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Ensho Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on...
Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BIOX) ("Biostax" or "the Company"), a biopharmaceutical company...
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
MIAMI, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular...
Tempus and Stemline Therapeutics, Inc., A Subsidiary of the Menarini Group, Announce Collaboration to Implement Tempus Next, an AI-Enabled Care Pathway Intelligence Platform to Support Patients with Metastatic Breast Cancer
Up to 50% of patients with ER+/HER2- mBC could develop ESR1 mutations as a result of prior exposure to endocrine...
Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,...
Inozyme Pharma to Present Recently Announced Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency at CHOP Cardiology 2025
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company...
Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering
Tampa, Florida, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (the "Company"), a holding company for various existing and...
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in...
Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
Extends cash runway well into mid-2026; no new/replacement warrants issuedKENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc....